Issue link: https://viewer.e-digitaledition.com/i/305172
05-731 Publisher: Dan Senkiw Managing Editor: Conner Armstrong President and Chief Executive Officer: Lud Kimbrough Chief Financial Officer: Elbert Johnson Chief Marketing Officer: Jason Skinner Vice President, B2B Brand Development: Carrie Dierks B2B Sales Director: Tim McNichols In Memoriam: Robert J. Brennan, Founder Account Manager: Kelsey McAuliffe Creative Director: Eric Jackson Designer: Brian Norman Creative Services: Steve Barrett, Aimee Burchard, Jamie Dent, Michael Ferguson, Kimmi Patterson, Michael Simmons, David Smith, Jennifer Webster Production: Ashley Clark, Allison Fincher Financial Services: April Charlton, Beverly Potter Audience Development: Debbie Dodski, David Enoch MD News is published by True North Custom 5600 Brainerd Road, Suite 1 Chattanooga, TN 37411 423-266-3234 | www.truenorthcustom.com Although every precaution is taken to ensure accuracy of published materials, MD News cannot be held responsible for opinions expressed or facts supplied by its authors. Copyright 2014, True North Custom. All rights reserved. Reproduction in whole or in part without written permission is prohibited. P O S T M A S T E R : Please send notices on Form 3579 to 5600 Brainerd Road, Suite 1, Chattanooga, TN 37411. Advertise in MD News For more information about advertising in the MD News Mid Hudson edition, call Publisher Dan Senkiw at 914-967-6565 or email dansenkiw@mdnews.com. Contact Information Send press releases and all other information related to this local edition of MD News to dansenkiw@mdnews.com or via fax to 914-967-1165. Mid Hudson green initiative M I N I M A L I M P A C T 05-852 from the Publisher T Dan Senkiw PUBLISHER Mid Hudson D A N S E N K I W @ M D N E W S . C O M 914-967-6565 HANKS FOR READING MD News Mid Hudson! I hope you enjoy the May 2014 issue. This month, as always, we provide updates about the local medical industry and perspective on healthcare trends from around the nation. Our cover feature focuses on women's health. We consider the remarkably slow acceptance of breast cancer prevention drugs — specifically chemoprevention through selective estrogen receptor modulators — among women considered to be at high risk for the disease yet at low risk for side effects. We also examine a Stanford University School of Medicine study addressing the potential to "awaken" ovarian tissue follicles and utilize hormones to stimulate egg development, a procedure that has led to healthy pregnancies among some Japanese women who had been infertile due to primary ovarian insufficiency. I invite readers to join the conversation about hea lt h ca re r ight here in our communit y by emailing me at dansenkiw@mdnews.com, visiting www.midhudson.mdnews.com or calling 914-967-6565. I look forward to your feedback, and I encourage you to follow MD News on Twitter for between-issue insights. Enjoy the magazine, Dan Senkiw 4 | Mid Hudson MD NEWS ■ M D N E W S . CO M